Our scientists have isolated a non-Cas9 nuclease for genome editing and developed a novel CRISPR-Cas tool. What does this imply for our own R&D and for customer projects?
Two steps forward, one step back – the path to perfect fermentation
Fermentation is part of the basic process of biotechnological production. If fermentation approaches are to be scaled up from laboratory to production scale, some approaches go from the already larger format back to the small laboratory format until the large-scale fermentation approach is ready. We asked two experts from BRAIN about fermentation, planning; the technical challenges and trends.
Biosun Biochemicals: Much more to offer than a traditional distributor
Biosun Biochemicals Inc.(U.S.) d/b/a BIOSUN FLAVORS & FOOD INGREDIENTS (BIOSUN FFI) has been part of the BRAIN Group since January 1, 2021. Among other things, it will help to expand the Group´s sales and manufacturing capacities in North America.
The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity has been in force for ten years. Here is an overview of the history of the agreement and an interview with BRAIN employee Dr. Dirk Sombroek on the significance of the agreement for biotechnology companies like BRAIN.
With the aim of promoting sustainable business practices, Germany has set out on the path to a bio-based economy. It is important to involve society in this transformation in order to shape this change towards more sustainability in a sustainable manner.
